Literature DB >> 17630931

The large and growing burden of stroke.

Seana L Paul1, Velandai K Srikanth, Amanda G Thrift.   

Abstract

Stroke is a disease with impacts ranging from death and disability, to reduced health-related quality of life and depression. To truly understand the burden of this disease we must investigate not only the mortality and prevalence of stroke, but also its incidence within populations. Stroke mortality and incidence declined rapidly during the 1980s and early 1990s; however, this trend appears to have slowed in more recent times. Despite many studies being conducted in Europe, and Australasia, there is a lack of reliable data from developing regions such as Asia and Africa. There are indications that although the mortality rate of stroke in such regions may be less than in developed countries, the simple fact that the populations are large means that the burden of stroke is considerable. Furthermore, as a result of epidemiological transition and rapid urbanization and industrialization many developing regions are exhibiting increased life expectancy, as well as changes in diet and other risk behaviors, such as smoking. This is contributing to a looming epidemic of stroke in these regions, as greater proportions of the population are now at risk of stroke. Fortunately, stroke is largely a preventable disease. The major risk factor for stroke, hypertension, can be controlled using both population-wide approaches, such as changes in the salt content of processed foods, and high-risk individual approaches, such as use of antihypertensive medications. Implementation of effective primary and secondary prevention strategies is likely to have an enormous benefit in reducing the burden of stroke, particularly in developing regions.

Entities:  

Mesh:

Year:  2007        PMID: 17630931     DOI: 10.2174/138945007781077418

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  23 in total

1.  Complementary and alternative medicine use among US adults with common neurological conditions.

Authors:  Rebecca Erwin Wells; Russell S Phillips; Steven C Schachter; Ellen P McCarthy
Journal:  J Neurol       Date:  2010-06-11       Impact factor: 4.849

2.  Metformin improves anxiety-like behaviors through AMPK-dependent regulation of autophagy following transient forebrain ischemia.

Authors:  Alireza Sarkaki; Yaghoob Farbood; Mohammad Badavi; Leila Khalaj; Fariba Khodagholi; Ghorbangol Ashabi
Journal:  Metab Brain Dis       Date:  2015-05-05       Impact factor: 3.584

3.  Oleoylethanolamide attenuates apoptosis by inhibiting the TLR4/NF-κB and ERK1/2 signaling pathways in mice with acute ischemic stroke.

Authors:  Hao Zhou; Wu-Shuang Yang; Ying Li; Tong Ren; Lu Peng; Han Guo; Jin-Feng Liu; Yu Zhou; Yun Zhao; Li-Chao Yang; Xin Jin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-10-13       Impact factor: 3.000

4.  Quercetin attenuates cell apoptosis in focal cerebral ischemia rat brain via activation of BDNF-TrkB-PI3K/Akt signaling pathway.

Authors:  Rui-Qin Yao; Da-Shi Qi; Hong-Li Yu; Jing Liu; Li-Hua Yang; Xiu-Xiang Wu
Journal:  Neurochem Res       Date:  2012-08-31       Impact factor: 3.996

5.  The Protective Effect of Remote Renal Preconditioning Against Hippocampal Ischemia Reperfusion Injury: Role of KATP Channels.

Authors:  Fatemeh Zare Mehrjerdi; Nahid Aboutaleb; Hamidreza Pazoki-Toroudi; Mansoureh Soleimani; Marjan Ajami; Mehdi Khaksari; Fatemeh Safari; Rouhollah Habibey
Journal:  J Mol Neurosci       Date:  2015-08-09       Impact factor: 3.444

Review 6.  Ageing populations: the challenges ahead.

Authors:  Kaare Christensen; Gabriele Doblhammer; Roland Rau; James W Vaupel
Journal:  Lancet       Date:  2009-10-03       Impact factor: 79.321

7.  IL-1alpha induces angiogenesis in brain endothelial cells in vitro: implications for brain angiogenesis after acute injury.

Authors:  Kathleen Salmeron; Takuma Aihara; Elena Redondo-Castro; Emmanuel Pinteaux; Gregory Bix
Journal:  J Neurochem       Date:  2015-11-27       Impact factor: 5.372

8.  Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats.

Authors:  Jesus M Pradillo; Adam Denes; Andrew D Greenhalgh; Herve Boutin; Caroline Drake; Barry W McColl; Eleanor Barton; Spencer D Proctor; James C Russell; Nancy J Rothwell; Stuart M Allan
Journal:  J Cereb Blood Flow Metab       Date:  2012-07-11       Impact factor: 6.200

Review 9.  A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention.

Authors:  Ji-Guang Wang
Journal:  Vasc Health Risk Manag       Date:  2009-08-06

10.  Pre-Treatment with Metformin in Comparison with Post-Treatment Reduces Cerebral Ischemia Reperfusion Induced Injuries in Rats.

Authors:  Mojtaba Karimipour; Sara Shojaei Zarghani; Majid Mohajer Milani; Hamid Soraya
Journal:  Bull Emerg Trauma       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.